EU MDR

EU Medical Device Regulation (EU MDR) – Chapter 6 – Clinical Evaluation and Clinical Investigations

This is a significant and exciting chapter introducing a life-cycle approach to ongoing CE Marking compliance; it is a process, not a project. One output of the clinical evaluation process is demonstrating clinical performance of the medical device, i.e. demonstrating that the device performs as intended and has benefit to patients. Clinical data in support of performance can come from many sources including: clinical literature, trials, usability, post-market clinical follow-up (PMCF), the state-of-the-art, and/or from “equivalent” devices.

CEU Credits: 0.1
Course Code: ELM-322
Duration: 45 mins
Skill Level: Intermediate
Language: English
Final Exam: Yes
Certification: Yes
Version: V1.0

Curriculum for this course

Previous Module
Module Introduction
Learning Objectives for this Module
Article 61 - Clinical Evaluation – Part 1
Article 61 - Clinical Evaluation – Part 2
Article 62 - General Requirements Regarding Clinical Investigations Conducted to Demonstrate Conformity of Devices – Part 1
Article 62 - General Requirements Regarding Clinical Investigations Conducted to Demonstrate Conformity of Devices – Part 2
Article 62 - General Requirements Regarding Clinical Investigations Conducted to Demonstrate Conformity of Devices – Part 3
Article 63 - Informed Consent
Article 64 - Clinical Investigations on Incapacitated Subjects
Article 65 - Clinical Investigations on Minors
Article 66 - Clinical Investigations on Pregnant or Breastfeeding Women
Article 67 - Additional National Measures
Article 68 - Clinical Investigations in Emergency Situations – Part 1
Article 68 - Clinical Investigations in Emergency Situations – Part 1
Article 69 - Damage Compensation
Article 70 - Application for Clinical Investigations
Article 71 - Assessment by Member States
Article 72 - Conduct of a Clinical Investigation
Article 73 - Electronic System on Clinical Investigations
Article 74 - Clinical Investigations Regarding Devices Bearing the CE Marking
Article 75 - Substantial modifications to Clinical Investigations
Article 76 - Corrective measures to be taken by Member States and Information Exchange Between Member States
Article 77 - Information From the Sponsor at the End of a Clinical Investigation or in the Event of a Temporary Halt or Early Termination – Part 1
Article 77 - Information From the Sponsor at the End of a Clinical Investigation or in the Event of a Temporary Halt or Early Termination – Part 2
Article 78 - Coordinated Assessment Procedure for Clinical Investigations – Part 1
Article 78 - Coordinated Assessment Procedure for Clinical Investigations – Part 2
Article 79 - Review of Coordinated Assessment Procedure
Article 80 - Recording and reporting of Adverse Events that Occur During Clinical Investigations
Article 81 - Implementing Acts
Article 82 - Requirements Regarding Other Clinical Investigations

Conclusion

Final Assessment

Certification

Author

Ian Nicholls

Director at Explic8

Courses

Browse our extensive catalog of GxP, Corporate Compliance and EH&S training.

Learning Strategy

Boost your organization’s training with LearnGxP’s Learning Strategy Consultants (LSC). They customize learning paths to match your needs, offering ongoing support for lasting success.

Customer Stories

Discover how LearnGxP addresses real challenges, provides effective solutions, and positively impacts our customers’ organizations.